calculated the risk to be 4.8/10,000 in groups taking GLP-1 RAs compared to 4.6/10,000 in the control groups, failing to show a statistically significant difference in aspiration or other complications between the two groups (Chang et al
The effectiveness of GLP-1 agonists can vary based on individual factors, making personalized treatment plans crucial for success
10.2174/1570159X22666231103085859 Summary Keywords deuterium, copper, histidine, amyloidogenic proteins, cardiolipin, mitochondrial dysfunction, neurodegeneration Citation Seneff S and Kyriakopoulos AM (2025) Deuterium trafficking, mitochondrial dysfunction, copper homeostasis, and neurodegenerative disease
These drugs by increasing insulin secretion and possibly, beta cell mass, decrease plasma glucose and lipids and have a secondary action to reduce food intake and bring about weight loss